-+ 0.00%
-+ 0.00%
-+ 0.00%

JP Morgan Maintains Overweight on Merck & Co, Raises Price Target to $165

Benzinga·10/05/2026 16:00:52
Listen to the news
JP Morgan analyst Chris Schott maintains Merck & Co (NYSE:MRK) with a Overweight and raises the price target from $150 to $165.